T1	Participants 16 47	chronic stable angina pectoris;
T2	Participants 318 659	13 randomized placebo-controlled trials published between 1960 and 1992 showed evidence of benefit for dipyridamole in the treatment of angina pectoris, especially with longer duration of treatment. Aim To assess the efficacy and safety of dipyridamole in the treatment of patients with chronic stable angina in a large scale, international,
T3	Participants 1205 1217	198 patients
T4	Participants 722 818	Four hundred patients with chronic stable angina pectoris and a positive treadmill exercise test
T5	Participants 2064 2155	patients with chronic stable angina treated with regular antianginal background medication,
